NEW YORK, March 27, 2017 /PRNewswire/ --
On Friday, benchmark US indices were in mixed colors as the NASDAQ Composite closed the trading session up 0.19%; the Dow Jones Industrial Average edged 0.29% lower; and the S&P 500 was down 0.08%. US markets made broad based gains with five out of nine sectors finishing the day in green. Pre-market today, Stock-Callers.com reviews these four Medical Appliances & Equipment stocks: Wright Medical Group N.V. (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), MiMedx Group Inc. (NASDAQ: MDXG), and Accuray Inc. (NASDAQ: ARAY). Learn more about these stocks by accessing their free research reports at:
On Friday, shares in Amsterdam, the Netherlands headquartered Wright Medical Group N.V. recorded a trading volume of 1.35 million shares, which was above their three months average volume of 916,670 shares. The stock ended the day 2.04% higher at $31.06. Wright Medical's stock has gained 10.26% in the last one month and 36.23% in the previous three months. Furthermore, the stock has rallied 92.68% in the past one year. The Company's shares are trading above its 50-day and 200-day moving averages by 14.70% and 31.15%, respectively. Furthermore, shares of Wright Medical Group, which designs, manufactures, markets, and sells extremities and biologics products in the US, Europe, the Middle East, Africa, and internationally, have a Relative Strength Index (RSI) of 80.77.
On March 21st, 2017, research firm Northcoast upgraded the Company's stock rating from 'Neutral' to 'Buy'. Free research report on WMGI is available at:
Salt Lake City, Utah headquartered Amedica Corp.'s stock finished Friday's session 3.23% higher at $0.40 with a total volume of 295,456 shares traded. Amedica's shares have advanced 3.98% in the past one month. The Company's shares are trading below its 50-day and 200-day moving averages by 6.79% and 46.98%, respectively. Shares of Amedica, which develops, manufactures, and sells a range of medical devices based on its silicon nitride ceramic technology platform in the US, Europe, and South America, have an RSI of 47.95. The complimentary research report on AMDA can be downloaded at:
Marietta, Georgia headquartered MiMedx Group Inc.'s stock advanced 2.02%, to close the day at $9.10. The stock recorded a trading volume of 547,934 shares. MiMedx's shares have gained 14.47% in the last one month, 3.76% in the previous three months, and 10.30% in the past one year. The Company's shares are trading 9.78% and 8.92% above its 50-day and 200-day moving averages, respectively. Shares of the Company, which develops, processes, and markets patent protected and proprietary regenerative biomaterial products and bioimplants processed from human placental tissue, skin, and bone, are trading at a PE ratio of 85.85. Additionally, the stock has an RSI of 67.09.
On March 03rd, 2017, research firm Piper Jaffray initiated an 'Overweight' rating on the Company's stock, with a target price of $10 per share. Visit us today and access our complete research report on MDXG at:
On Friday, shares in Sunnyvale, California headquartered Accuray Inc. ended the session 1.03% lower at $4.80 with a total volume of 648,189 shares traded. Accuray's shares have advanced 1.05% in the past three months. The stock is trading 9.47% below its 50-day moving average and 9.25% below its 200-day moving average. Moreover, shares of the Company, which designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body, have an RSI of 36.89. Get free access to your research report on ARAY at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44-330-808-3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA